Back

MAIA Biotechnology to Allocate 90% of Liquid Assets to Cryptocurrencies

The NYSE American-listed firm plans initial investments in BTC, ETH, and USDC, supported by a new digital asset advisory committee.

BTC
ETH
USDC

Summary

MAIA Biotechnology has adopted a crypto treasury strategy approved by its board to invest 90% of its liquid assets in leading cryptocurrencies. The first purchases will involve Bitcoin (BTC), Ethereum (ETH), and USD Coin (USDC). The NYSE American-listed company will also establish a digital asset advisory committee to oversee related transactions.

Terms & Concepts
  • Crypto Treasury Strategy: A corporate financial approach involving the allocation of a portion of a company’s liquid assets into cryptocurrencies for diversification or potential returns.
  • BTC: Abbreviation for Bitcoin, the first and most widely recognized decentralized cryptocurrency.
  • USDC: USD Coin, a stablecoin pegged to the U.S. dollar, designed to maintain price stability.